Cover image of the article: Human Umbilical Cord Mesenchymal Stem Cells-Derived Exosomes Can Alleviate the Proctitis Model Through TLR4/NF-Kb Pathway

Image Credit:J Cell Mol Anesth

Human Umbilical Cord Mesenchymal Stem Cells-Derived Exosomes Can Alleviate the Proctitis Model Through TLR4/NF-Kb Pathway

Authors

Zahra Ebrahim Soltani1,*, Mohammad Elahi2, Hasti Tashak-Golroudbari3, Abolfazl Badripour 3, Hojjatollah Nazari 4, Asieh Heirani-Tabasi1, Reza Akbari Asbagh 3, Mohammad Amin Dabbagh Ohadi 3, Moojan Shabani 3, Mina Mahboudi3, Mojdeh Sarzaeim 3, alireza mahdavi2, Behnam Behboudi5, Mohammad Reza Keramati5, Alireza Kazemeini5, Seyed Mohsen Ahmadi Tafti6
1Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
2School of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
3School of Medicine, Tehran University of Medical Science, Tehran, Iran.
4School of Biomedical Engineering, University of Technology Sydney, Sydney, New South Wales 2007, Australia.
5Colorectal Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Science, Tehran, Iran.
6Colorectal Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Science, Tehran, Iran
*Corresponding Author: Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. Email: zahra_esoltani@yahoo.com

Journal of Cellular & Molecular Anesthesia:Vol. 8, issue 4; e149754
Published online:Mar 09, 2023
Article type:Original Articles
How to Cite:Ebrahim Soltani Z, Elahi M, Tashak-Golroudbari H, Badripour A, Nazari H, et al. Human Umbilical Cord Mesenchymal Stem Cells-Derived Exosomes Can Alleviate the Proctitis Model Through TLR4/NF-Kb Pathway. J Cell Mol Anesth. 2023;8(4):e149754. doi: https://doi.org/10.22037/jcma.v8i4.41127

Abstract

Background: Proctitis is a significant concern of inflammatory bowel diseases, especially ulcerative colitis. Exosomes are a new method for treating many diseases by their immunosuppressive and tissue-repairing potential. Here, we tried Mesenchymal stem cells (MSCs)-derived Exosomes for treating the proctitis model of rats. Materials and Methods: Rats were assigned into four groups: sham, control group, rectal, and intraperitoneal exosome injection. The proctitis model was induced by rectal administration of 4% acetic acid. The exosome was derived from human MSCs isolated from human umbilical cords. After seven days, rectum samples were assessed for histopathological, IHC, and PCR analysis. Results: The histopathologic scores, collagen deposition, and the expression of NF-?B, TLR4, TNF?, IL-6, and TGF? were decreased in intraperitoneal exosome compared to controls. The result was not promising for the rectal administration of exosomes. Conclusion: Exosomes can suppress the inflammatory response in the proctitis model and improve the rectum's healing process. Exosomes can inhabit the NF-?B/TLR4 pathway and downstream pro-inflammatory cytokines. This study implicates the therapeutic benefits of exomes in treating proctitis.

Highlights

References

  • 1.
    References are in the PDF file of the article.

Copyright

© 2023, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

25
May
2025
Poly(I:C)-Stimulated Exosomes Mitigate Cholesterol-Induced Hepatic Fibrosis by Modulating the TGF-β/Smad3 Signal Transduction Pathway

Poly(I:C)-Stimulated Exosomes Mitigate Cholesterol-Induced Hepatic Fibrosis by Modulating the TGF-β/Smad3 Signal Transduction Pathway

Shahla Asadizadeh,
Parichehreh Yaghmaei,
Nasim Hayati Roodbari,
Azam Khedri

Asadizadeh S, Yaghmaei P, Hayati Roodbari N, Khedri A. Poly(I:C)-Stimulated Exosomes Mitigate Cholesterol-Induced Hepatic Fibrosis by Modulating the TGF-β/Smad3 Signal Transduction Pathway. Hepat Mon. 2025;25(1):e160481. doi: https://doi.org/10.5812/hepatmon-160481

24
Sep
2019
Endometrial Mesenchymal Stem Cell-Derived Exosome Promote Endothelial Cell Angiogenesis in a Dose Dependent Manner: A New Perspective on Regenerative Medicine and Cell-Free Therapy

Endometrial Mesenchymal Stem Cell-Derived Exosome Promote Endothelial Cell Angiogenesis in a Dose Dependent Manner: A New Perspective on Regenerative Medicine and Cell-Free Therapy

Vajihe Taghdiri Nooshabadi,
Javad Verdi,
Somayeh Ebrahimi-Barough,
Javad Mowla,
Mohammad Ali Atlasi,
Tahereh Mazoochi
,et al.

Taghdiri Nooshabadi V, Verdi J, Ebrahimi-Barough S, Mowla J, Atlasi MA, et al. Endometrial Mesenchymal Stem Cell-Derived Exosome Promote Endothelial Cell Angiogenesis in a Dose Dependent Manner: A New Perspective on Regenerative Medicine and Cell-Free Therapy. Arch Neurosci. 2019;6(4):e94041. doi: https://doi.org/10.5812/ans.94041

16
Sep
2019
The Effect of Mesenchymal Stem Cells Pulsed with 17 Beta-Estradiol in an Ameliorating Rat Model of Ulcerative Colitis

The Effect of Mesenchymal Stem Cells Pulsed with 17 Beta-Estradiol in an Ameliorating Rat Model of Ulcerative Colitis

Seyyed Meysam Abtahi Froushani,
Siavash Mashhouri

Abtahi Froushani SM, Mashhouri S. The Effect of Mesenchymal Stem Cells Pulsed with 17 Beta-Estradiol in an Ameliorating Rat Model of Ulcerative Colitis. Zahedan J Res Med Sci. 2019;21(4):e83762. doi: https://doi.org/10.5812/zjrms.83762

2
Aug
2020
Application of extracellular vesicles in the treatment of inflammatory bowel disease

Application of extracellular vesicles in the treatment of inflammatory bowel disease

neda heidari,
Hajar Abbasi,
Kaveh Baghaei,
Saeed Namaki,
Seyed Mahmoud Hashemi

heidari N, Abbasi H, Baghaei K, Namaki S, Hashemi SM. Application of extracellular vesicles in the treatment of inflammatory bowel disease. koomesh. 2020;22(2):e153171. doi:

2
Dec
2023
Pretreatment of Exosomes Derived from hUCMSCs with LPS Ameliorates Liver Fibrosis by Inhibiting the Smad3C Through Upregulating MiR-126 in the HSC-T6 Cell Line

Pretreatment of Exosomes Derived from hUCMSCs with LPS Ameliorates Liver Fibrosis by Inhibiting the Smad3C Through Upregulating MiR-126 in the HSC-T6 Cell Line

Maryam Cheraghzadeh,
Emad Matour,
Benyamin Kabizadeh,
Elham Shakerian,
Mojtaba Rashidi

Cheraghzadeh M, Matour E, Kabizadeh B, Shakerian E, Rashidi M. Pretreatment of Exosomes Derived from hUCMSCs with LPS Ameliorates Liver Fibrosis by Inhibiting the Smad3C Through Upregulating MiR-126 in the HSC-T6 Cell Line. Hepat Mon. 2023;23(1):e137083. doi: https://doi.org/10.5812/hepatmon-137083

More by these authors

Zahra Ebrahim SoltaniPubMedScholar
Mohammad ElahiPubMedScholar
Hasti Tashak-GolroudbariPubMedScholar
Abolfazl BadripourPubMedScholar
Hojjatollah NazariPubMedScholar
Asieh Heirani-TabasiPubMedScholar
Reza Akbari AsbaghPubMedScholar
Mohammad Amin Dabbagh OhadiPubMedScholar
Moojan ShabaniPubMedScholar
Mina MahboudiPubMedScholar
Mojdeh SarzaeimPubMedScholar
alireza mahdaviPubMedScholar
Behnam BehboudiPubMedScholar
Mohammad Reza KeramatiPubMedScholar
Alireza KazemeiniPubMedScholar
Seyed Mohsen Ahmadi TaftiPubMedScholar
Share
Cited by
Metrics
Indexed in